Prognostic significance of lymph node yield and lymph node ratio in patients affected by squamous cell carcinoma of the oral cavity and oropharynx: Study protocol for a prospective, multicenter, observational study

Oreste Iocca, Alessio Farcomeni, Armando De Virgilio, Pasquale Di Maio, Paweł Golusinski, Luca Malvezzi, Raul Pellini, Wojciech Golusinski, Christopher H Rassekh, Giuseppe Spriano, Oreste Iocca, Alessio Farcomeni, Armando De Virgilio, Pasquale Di Maio, Paweł Golusinski, Luca Malvezzi, Raul Pellini, Wojciech Golusinski, Christopher H Rassekh, Giuseppe Spriano

Abstract

Background: Lymph node involvement is a fundamental prognostic factor in head and neck squamous cell carcinoma (SCC). Lymph node yield (LNY), which is the number of lymph nodes retrieved after neck dissection, and lymph node ratio (LNR), which is the ratio of positive lymph nodes out of the total removed, are measurable indicators that may have the potential to be used as prognostic factors. The present study is designed to define the exact role of LNY and LNR regarding the overall and specific survival of patients affected by oral cavity and oropharyngeal SCC. It has been registered on clinicaltrials.gov database (NCT03534778).

Methods: This is a multicenter study involving tertiary care referral centers in Europe and North America. Patients affected by oral cavity, HPV+ and HPV- oropharyngeal SCC undergoing neck dissection will be consecutively enrolled and followed-up for up to 5 years. Patients and disease characteristic will be properly recorded and centrally analyzed. The primary end-point is to define reliable cut off-values for LNY and LNR which may serve as prognosticators of survival. This will be achieved through the use of ROC curves. Secondary outcomes will be the Overall survival (OS), Disease Specific Survival (DSS), and Progression Free Survival Hazard Ratios (HR) at 2-, 3- and 5 years, which will be evaluated through the Kaplan-Meier method and the difference in survival attested by the log-rank test. Univariate and multivariate analysis will be performed to understand the association of various outcomes with LNY and LNR.

Figures

Fig. 1
Fig. 1
Schematization of data collection.

References

    1. Lydiatt W. Head and neck cancers-major changes in the American Joint committe on cancer eighth edition cancer staging manual. Ca - Cancer J. Clin. 2017;67:122–137.
    1. Cheraghlou S. Prognostic value of lymph node yield and density in head and neck malignancies. Otolaryngol. Head Neck Surg. 2018 United States.
    1. Talmi Y.P., Takes R.P., Alon E.E. Prognostic value of lymph node ratio in head and neck squamous cell carcinoma. Head Neck. 2018;40:1082–1090.
    1. von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 2008 Apr;61(4):344–349.
    1. Rosenberg J., Henriksen N.A., Jørgensen L.N. Vol. 11. 2010. Multicenter data acquisition made easy Trials; p. 49. Published online 2010 Apr 30.
    1. Robbins K.T., Clayman G., Levine P.A. Neck dissection classification UpdateRevisions proposed by the American head and neck society and the American academy of otolaryngology–head and neck surgery. Arch. Otolaryngol. Head Neck Surg. 2002;128(7):751–758.
    1. Ogundimu E., Altman D.G., Collins G.S. Adequate sample size for developing prediction models is not simply related to events per variable. J. Clin. Epidemiol. 2016 Aug;76:175–182.
    1. Ebrahimi A., Zhang W.J., Gao K., Clark J.R. vol 117. 2011. pp. 2917–2925. (Nodal Yield and Survival in Oral Squamous Cancer: Defining the Standard of Care Cancer).
    1. Kuo P., Mehra S., Sosa J.A. Proposing prognostic thresholds for lymph node yield in clinically lymph node-negative and lymph node-positive cancers of the oral cavity. Cancer. 2016;122:3624–3631.
    1. Divi V., Harris J., Harari P.M. Establishing quality indicators for neck dissection: correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234) Cancer. 2016;122:3464–3471.
    1. Bottcher A., Dommerich S., Sander S. Nodal yield of neck dissections and influence on outcome in laryngectomized patients. Eur. Arch. Oto-Rhino-Laryngol. 2016;273:3321–3329.
    1. Shrime M.G., Bachar G., Lea J. Nodal ratio as an independent predictor of survival in squamous cell carcinoma of the oral cavity. Head Neck. 2009;31:1482–1488.
    1. Gil Z., Carlson D.L., Boyle J.O. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer. 2009;115:5700–5710.
    1. Kunzel J., Mantsopoulos K., Psychogios G., Grundtner P., Koch M., Iro H. Lymph node ratio as a valuable additional predictor of outcome in selected patients with oral cavity cancer. Oral Surg. Oral Med. Oral. Pathol. Oral Radiol. 2014;117:677–684.
    1. Chassin M.R., Loeb J.M., Schmaltz S.P., Wachter R.M. Accountability measures—using measurement to promote quality improvement. N. Engl. J. Med. 2010;363:683–688.
    1. Lemieux A., Kedarisetty S., Raju S., Orosco R., Coffey C. Lymph node yield as a predictor of survival in pathologically node negative oral cavity carcinoma. Otolaryngol. Head Neck Surg. 2016;154:465–472.
    1. Lee S., Kim H.J., Cha I.H., Nam W. Prognostic value of lymph node count from selective neck dissection in oral squamous cell carcinoma. Int. J. Oral Maxillofac. Surg. 2018;47(8):953–958. Aug.
    1. Ebrahimi A., Clark J.R., Amit M. Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study. Ann. Surg. Oncol. 2014;21:3049–3305.
    1. Shrime M.G., Ma C., Gullane P.J. Impact of nodal ratio on survival in squamous cell carcinoma of the oral cavity. Head Neck. 2009;31:1129–1136.
    1. Patel S.G., Amit M., Yen T.C. Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research. Br. J. Canc. 2013;109:2087–2095.
    1. Suzuki H., Matoba T., Hanai N. Lymph node ratio predicts survival in hypopharyngeal cancer with positive lymph node metastasis. Eur. Arch. Oto-Rhino-Laryngol. 2016;273:4595–4600.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir